Pharmaceutical companies are a critical part of the US health care system and it is essential that we participate, actively and responsibly, in the political process to help ensure sound public policy on health care issues.
The success of these efforts depends to a great extent on our involvement at the national, state, and local level. Together, we can build a stronger health care system in which more people are diagnosed and treated, fewer people are hospitalized, and medicines are properly seen as an investment, not a cost.
Learn more about each of our efforts below.
AstraZeneca Political Action Committee (AZPAC)
AstraZeneca's Political Action Committee (PAC) provides eligible U.S. employees an opportunity to support federal and state candidates who share the company's perspective on the public policies that impact our business and the patients we serve.
AZPAC is funded solely by voluntary employee contributions. AZPAC's Board of Directors, comprised of representatives from different units of AstraZeneca, directs AZPAC's communications, contributions and membership programs. The AZPAC Board determines which candidates will receive support, without regard to their party affiliation, based on the candidate's understanding and support of issues important to AstraZeneca and the biopharmaceutical industry, the candidate's membership on key committees that consider legislation vital to our business, the location of AstraZeneca/MedImmune employees and/or facilities in the candidate’s state or district, the candidate’s leadership position or potential for leadership, and the candidate’s financial need and potential for winning.
AZPAC is registered with the Federal Election Commission (FEC) (www.fec.gov) as Zeneca Inc. PAC and complies with all regulatory requirements, including stringent reporting and record keeping and strict contribution limits. AZPAC also provides required reports to the appropriate state agencies.
Corporate political contributions
Through corporate contributions, where permissible, AstraZeneca supports state candidates who share the company’s perspective on the public policies that impact our business and the patients we serve. AstraZeneca supports policies that promote market competition, expand coverage for the uninsured, ensure that patient safety is maintained and enhanced, foster and reward innovation, and provide protection for intellectual property.
As a leader in the healthcare industry, AstraZeneca is committed to sharing its knowledge and experience with government officials and policy makers as they address healthcare-related issues that impact patients and caregivers.
AstraZeneca has strict internal policies that oversee interactions between AstraZeneca employees and government officials. Federal and state laws and regulations also govern lobbying activities.
AstraZeneca and other entities are required to register lobbyists with and report federal lobbying activities to the Clerk of the House of Representatives and the Secretary of the Senate. These quarterly reports are available below. These reported expenditures include the portion of AstraZeneca’s trade associations dues used for political purposes. AstraZeneca separately discloses this expenditure for major trade associations on this webpage.